Physician profile
Amy Potter
NPI 1033201454
$835.25
in general payments reported to CMS, 2019-2025
17 companies · $772 in 2025
The $772 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.22 · 2023: $28.18 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $177.31 | 2025 | |
| Beta Bionics, INC. | $91.76 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Tolmar, INC. | $91.55 | 2023-2025 | Fensolvi |
| Novo Nordisk INC | $86.04 | 2025 | Sogroya, Wegovy |
| Eton Pharmaceuticals, INC. | $45.32 | 2025 | Khindivi, Increlex, Alkindi |
| Ascendis Pharma Endocrinology INC | $43.76 | 2025 | Skytrofa |
| Kyowa Kirin, INC. | $42.54 | 2025 | |
| Pfizer INC. | $39.38 | 2025 | |
| Rhythm Pharmaceuticals, INC. | $31.98 | 2022-2025 | Imcivree |
| Regeneron Healthcare Solutions, INC. | $29.85 | 2025 | Evkeeza |
| Sanofi Pasteur INC. | $26.64 | 2025 | |
| Azurity Pharmaceuticals, INC. | $26.18 | 2025 | Triptodur |
| Neurocrine Biosciences, INC. | $23.49 | 2025 | |
| Abbott Laboratories | $22.41 | 2025 | Freestyle Libre 3 |
| Sequel Med Tech, LLC | $19.78 | 2025 | Twiist |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $18.63 | 2022 | |
| Lilly USA, LLC | $18.63 | 2025 | Kisunla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.